Cell Impact AB (publ) announced that Stefan Axellie, has decided to leave his role and Cell Impact by spring 2024. The process of identifying a successor will start within short. Stefan Axellie will stay on in his role until spring 2024 during the recruitment of his successor.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2245 SEK | -7.04% | -25.08% | +0.22% |
May. 14 | Cell Impact AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Cell Impact AB Signs Main Agreement with F.C.C | CI |
1st Jan change | Capi. | |
---|---|---|
+0.22% | 13.56M | |
+53.93% | 3.9B | |
-7.83% | 1.87B | |
-9.51% | 1.79B | |
-5.97% | 1.77B | |
-2.28% | 1.6B | |
+3.63% | 1.51B | |
+59.11% | 1.37B | |
+9.04% | 1.3B | |
+17.20% | 1.16B |
- Stock Market
- Equities
- CI Stock
- CI Stock
- News Cell Impact AB (publ)
- Cell Impact AB Announces That Stefan Axellie to Leave Role as CFO